Catalyst Wire Dossier Catalyst Wire Dossier

Xiyanping Injection

Xiyanping · Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Xiyanping Injection, covering 2010-08-17 to 2025-01-01. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Clinical Value and Safety of Xiyanping Injection in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease(COPD) Based on Real-world Clinical Data

See pricing